Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QX0K
|
|||
| Former ID |
DIB013818
|
|||
| Drug Name |
FT-105
|
|||
| Synonyms |
FT-105 (long-acting, Medusa), Flamel
Click to Show/Hide
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Discontinued in Phase 1 | [1] | |
| Company |
Flamel Technologies SA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013224) | |||
| REF 2 | Degludec insulin: A novel basal insulin. Indian J Endocrinol Metab. 2011 July; 15(Suppl1): S12-S16. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.